Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy
- PMID: 15464672
- DOI: 10.1016/j.amjcard.2004.06.024
Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy
Abstract
Predictors of the development of atrial fibrillation (AF) in patients who have hypertrophic cardiomyopathy (HC) have not been extensively studied, although, in these patients, AF contributes to the exacerbation of symptoms and the development of heart failure. The present study determined the role of left atrial (LA) function in the development of AF in patients who have HC. One hundred fifty consecutive patients who had HC, had no history of AF, and who were followed for 5.2 +/- 2.9 years constituted the study population. Using M-mode echocardiography, we measured LA function as global LA fractional shortening and LA diameter. LA volume was measured from 2-dimensional 4-chamber views by the method of disks. During follow-up, 20 patients developed AF. LA function was an independent predictor of AF (odds ratio 0.716, p = <0.001), whereas LA diameter and volume were predictors in addition to age. Kaplan-Meier analysis showed that LA dysfunction carried a high risk of AF. Thus, in patients who have HC, LA function is a strong predictor of AF development and is independent of age.
Similar articles
-
Left Atrial Size and Function in Hypertrophic Cardiomyopathy Patients and Risk of New-Onset Atrial Fibrillation.Circ Arrhythm Electrophysiol. 2017 Feb;10(2):e004052. doi: 10.1161/CIRCEP.116.004052. Circ Arrhythm Electrophysiol. 2017. PMID: 28183843
-
Left atrial remodeling in hypertrophic cardiomyopathy and susceptibility markers for atrial fibrillation identified by cardiovascular magnetic resonance.Am J Cardiol. 2014 Apr 15;113(8):1394-400. doi: 10.1016/j.amjcard.2013.12.045. Epub 2014 Jan 31. Am J Cardiol. 2014. PMID: 24589281
-
Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy).Am J Cardiol. 2006 Oct 1;98(7):960-5. doi: 10.1016/j.amjcard.2006.05.013. Epub 2006 Aug 14. Am J Cardiol. 2006. PMID: 16996883
-
E/e' ratio and left atrial area are predictors of atrial fibrillation in patients with hypertrophic cardiomyopathy.Echocardiography. 2018 Jul;35(7):935-940. doi: 10.1111/echo.13857. Epub 2018 Mar 5. Echocardiography. 2018. PMID: 29505666
-
[Assessment of left atrial size and function].Kardiol Pol. 2012;70(10):1046-52. Kardiol Pol. 2012. PMID: 23080099 Review. Polish. No abstract available.
Cited by
-
A primer on arrhythmias in patients with hypertrophic cardiomyopathy.Curr Cardiol Rep. 2012 Oct;14(5):552-62. doi: 10.1007/s11886-012-0297-3. Curr Cardiol Rep. 2012. PMID: 22825919 Review.
-
Hypertrophic cardiomyopathy and atrial fibrillation: the Cardiomyopathy/Myocarditis Registry of the EURObservational Research Programme of the European Society of Cardiology.Open Heart. 2025 Feb 17;12(1):e002876. doi: 10.1136/openhrt-2024-002876. Open Heart. 2025. PMID: 39961701 Free PMC article.
-
Relationship between atrial fibrillation and blunted hyperemic myocardial blood flow in patients with hypertrophic cardiomyopathy.J Nucl Cardiol. 2009 Jan-Feb;16(1):92-6. doi: 10.1007/s12350-008-9005-5. Epub 2009 Jan 20. J Nucl Cardiol. 2009. PMID: 19152133
-
Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical correlations, and mortality in a large high-risk population.J Am Heart Assoc. 2014 Jun 25;3(3):e001002. doi: 10.1161/JAHA.114.001002. J Am Heart Assoc. 2014. PMID: 24965028 Free PMC article.
-
Atrial Fibrillation and Anticoagulation in Hypertrophic Cardiomyopathy.Arrhythm Electrophysiol Rev. 2017 Jun;6(2):63-68. doi: 10.15420/aer.2017.4.2. Arrhythm Electrophysiol Rev. 2017. PMID: 28835837 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical